Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPAD-CKD: Intensive BP Control in T2DM
NCT04978649Phase 4Withdrawn
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2021
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of allisartan isoproxil in hypertension (HTN), sponsored by Guangdong Provincial People's Hospital. Planned start Sep 2021; status: withdrawn.
02
Drugs
allisartan isoproxil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04978649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04978649.